247 related articles for article (PubMed ID: 28628344)
1. Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener's).
You C; Ma L; Lasave AF; Foster CS
Ocul Immunol Inflamm; 2018; 26(8):1166-1173. PubMed ID: 28628344
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
4. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Azar L; Springer J; Langford CA; Hoffman GS
Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
[TBL] [Abstract][Full Text] [Related]
5. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide or Rituximab Treatment of Scleritis and Uveitis for Patients with Granulomatosis with Polyangiitis.
Ahmed A; Foster CS
Ophthalmic Res; 2019; 61(1):44-50. PubMed ID: 29635229
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis.
Besada E; Koldingsnes W; Nossent JC
Rheumatology (Oxford); 2014 Oct; 53(10):1818-24. PubMed ID: 24831059
[TBL] [Abstract][Full Text] [Related]
8. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
Brogan P; Yeung RSM; Cleary G; Rangaraj S; Kasapcopur O; Hersh AO; Li S; Paripovic D; Schikler K; Zeft A; Bracaglia C; Eleftheriou D; Pordeli P; Melega S; Jamois C; Gaudreault J; Michalska M; Brunetta P; Cooper JC; Lehane PB;
Arthritis Rheumatol; 2022 Jan; 74(1):124-133. PubMed ID: 34164952
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.
Puéchal X; Iudici M; Calich AL; Vivot A; Terrier B; Régent A; Cohen P; Jeunne CL; Mouthon L; Ravaud P; Guillevin L
Rheumatology (Oxford); 2019 Mar; 58(3):401-409. PubMed ID: 29722877
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
Cartin-Ceba R; Golbin JM; Keogh KA; Peikert T; Sánchez-Menéndez M; Ytterberg SR; Fervenza FC; Specks U
Arthritis Rheum; 2012 Nov; 64(11):3770-8. PubMed ID: 22730028
[TBL] [Abstract][Full Text] [Related]
12. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile and management of granulomatosis with polyangiitis-associated scleritis from a tertiary care hospital in South India.
Mohanan-Earatt A; Biswas J
Indian J Ophthalmol; 2023 Jan; 71(1):146-152. PubMed ID: 36588225
[TBL] [Abstract][Full Text] [Related]
14. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's).
Lally L; Lebovics RS; Huang WT; Spiera RF
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1403-9. PubMed ID: 25299002
[TBL] [Abstract][Full Text] [Related]
16. Worsening of posterior scleritis and orbital pseudotumor in a patient with granulomatosis polyangiitis with rituximab-A case report.
Babu K; Dharmanand BG
Indian J Ophthalmol; 2020 Sep; 68(9):1986-1988. PubMed ID: 32823451
[TBL] [Abstract][Full Text] [Related]
17. Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis).
Tavakolpour S; Alesaeidi S
Int Immunopharmacol; 2019 May; 70():67-68. PubMed ID: 30785092
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series.
Knight A; Hallenberg H; Baecklund E
Clin Rheumatol; 2014 Jun; 33(6):841-8. PubMed ID: 23959445
[TBL] [Abstract][Full Text] [Related]
19. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
Singer O; McCune WJ
Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
[TBL] [Abstract][Full Text] [Related]
20. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
